0001209191-23-031518.txt : 20230522
0001209191-23-031518.hdr.sgml : 20230522
20230522170509
ACCESSION NUMBER: 0001209191-23-031518
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230518
FILED AS OF DATE: 20230522
DATE AS OF CHANGE: 20230522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosenberg Adam Joseph
CENTRAL INDEX KEY: 0001867407
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40708
FILM NUMBER: 23945453
MAIL ADDRESS:
STREET 1: C/O ELIEM THERAPEUTICS, INC.
STREET 2: 23515 NE NOVELTY HILL RD, STE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eliem Therapeutics, Inc.
CENTRAL INDEX KEY: 0001768446
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832273741
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 23515 NE NOVELTY HILL ROAD
STREET 2: SUITE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
BUSINESS PHONE: 877-354-3689
MAIL ADDRESS:
STREET 1: 23515 NE NOVELTY HILL ROAD
STREET 2: SUITE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-18
0
0001768446
Eliem Therapeutics, Inc.
ELYM
0001867407
Rosenberg Adam Joseph
C/O ELIEM THERAPEUTICS, INC.
23515 NE NOVELTY HILL RD, STE. B221 #125
REDMOND
WA
98053
1
0
0
0
0
Common Stock
178100
D
Stock Option (Right To Buy)
3.00
2023-05-18
4
A
0
10000
0.00
A
2033-05-17
Common Stock
10000
10000
D
The shares subject to the option will vest on the earlier of May 18, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.
/s/ Brian Woodard, Attorney-in-Fact
2023-05-22